ORPHAZYME TO PRESENT AT COWEN & CO. 38TH ANNUAL HEALTH CARE CONFERENCE

Copenhagen, March 9, 2018 – Orphazyme A/S, a biopharmaceutical company dedicated to developing treatments for patients living with rare diseases, today announced that Anders Hinsby, Chief Executive Officer at Orphazyme, will be presenting at the Cowen & Co. 38th Annual Health Care Conference in Boston, Massachusetts, USA on March 12, 2018 at 2:10-2:40 PM EST.